Peptides for the Brain
The nootropic community has discovered peptides, and two names keep coming up: Selank and Semax. Both were developed in Russia, both are approved there as medications, and both are being used by Western biohackers who order them from research chemical suppliers.
The appeal is obvious: prescription-grade cognitive enhancers that work through peptide signaling rather than traditional stimulants. But the reality is more nuanced than the Reddit threads suggest.
Selank: The Anxiolytic
Selank is a synthetic analog of tuftsin, an immunomodulatory peptide. It was developed at the Institute of Molecular Genetics in Moscow and approved in Russia as an anxiolytic — a medication that reduces anxiety.
How it works
Selank modulates GABA, serotonin, and dopamine systems while enhancing BDNF (brain-derived neurotrophic factor) expression. It also stabilizes enkephalins — natural peptides involved in stress response. The mechanism is fundamentally different from benzodiazepines or SSRIs.
What the evidence shows
- Approved in Russia based on clinical studies showing anxiolytic effects
- Multiple animal studies confirm reduced anxiety-like behavior
- Small human studies show decreased anxiety scores on standardized measures
- Shown to increase BDNF expression in animal models
What's missing
- Studies are predominantly small, often open-label, and published in Russian journals
- Independent Western replication is essentially absent
- Long-term safety data is sparse
- The transition from Russian regulatory approval to Western-standard evidence is not straightforward — different standards, different trial designs
Semax: The Neuroprotector
Semax is a synthetic analog of ACTH (adrenocorticotropic hormone) fragment 4-10. Approved in Russia and Ukraine, it's used clinically for stroke recovery and cognitive disorders.
How it works
Semax increases BDNF and NGF (nerve growth factor), supporting neuronal survival and synaptic plasticity. Unlike full ACTH, it does not stimulate cortisol production — making it neurologically targeted without the hormonal baggage.
What the evidence shows
- Approved for stroke recovery and cognitive impairment in Russia/Ukraine
- Demonstrated neuroprotective effects in ischemic stroke models
- Increases BDNF and NGF levels across multiple studies
- Does not affect cortisol despite being an ACTH analog
What's missing
- Same limitations as Selank: small trials, Russian-language publications, limited independent replication
- Western-standard randomized controlled trials are lacking
- Long-term effects of sustained neurotrophic factor elevation are not fully understood
The Evidence Comparison
| Factor | Selank | Semax |
|---|---|---|
| Primary use | Anxiety reduction | Cognitive enhancement, neuroprotection |
| Approved where | Russia | Russia, Ukraine |
| FDA status | Not approved | Not approved |
| Delivery | Nasal spray | Nasal spray |
| Key mechanism | GABA/serotonin modulation, BDNF | BDNF/NGF elevation |
| Human trial quality | Small, mostly Russian | Small, mostly Russian |
| Cortisol effects | None reported | None (despite ACTH origin) |
| Common side effects | Mild, rarely reported | Mild, rarely reported |
The Regulatory Gap
These peptides exist in a strange middle ground. They're not underground research chemicals like BPC-157 — they've been through clinical development and regulatory approval in their home countries. But they haven't gone through the FDA process, and the clinical evidence doesn't meet the standards that Western regulators require.
"Approved in Russia" is not the same as "FDA approved," but it's also not the same as "unregulated research chemical." The truth is somewhere in between, and honest assessment requires acknowledging that uncertainty rather than collapsing it into either direction.
This matters because Western biohackers are using these peptides based on a combination of:
- The legitimate Russian clinical data (real but limited)
- Anecdotal reports from online communities (unreliable)
- The assumption that Russian approval equals proven efficacy (oversimplified)
Practical Considerations
If you're considering nootropic peptides
- Understand that you're in genuinely uncertain territory — the peptides likely have real biological activity, but the evidence base is thinner than advocates suggest
- Work with a physician, particularly if you're taking psychiatric medications — interactions are theoretically possible but unstudied
- Compounded nasal sprays vary in quality. There are no guaranteed standards for products purchased from research chemical suppliers
- These are not replacements for professional mental health treatment. Anxiety and cognitive issues have many causes that peptides don't address
- Start conservatively if you proceed. The "more is better" approach has no evidence base
What about BPC-157 for the brain?
Some biohackers use BPC-157 for cognitive purposes based on animal data showing neurological effects. The evidence for this use case is even thinner than for Selank and Semax — there are no human studies specifically examining BPC-157's cognitive effects, and extrapolating from rodent models to human cognition is particularly unreliable.
The Bottom Line
Selank and Semax are among the more credible peptides in the nootropic space — they have real clinical data, approved medical uses, and plausible mechanisms. But "more credible than most nootropic peptides" is a low bar. The evidence doesn't yet support the confident claims made in biohacking communities, and using them involves accepting genuine uncertainty about long-term effects.
The most honest framing: these are potentially interesting compounds with preliminary evidence that warrant further research — not proven cognitive enhancers ready for widespread use.